Piribedil: International drug information (concise)
For abbreviations, symbols, and age group definitions used in Lexicomp (
show table)
International Brand Names
International Brand Names by CountryFor country code abbreviations (
show table)
-
(AE) United Arab Emirates: Trivastal;
-
(AR) Argentina: Trastoner;
-
(BF) Burkina Faso: Trivastal lp;
-
(BR) Brazil: Trivastal;
-
(CN) China: Trastal;
-
(DE) Germany: Clarium | Trivastal;
-
(EG) Egypt: Cerebrodil;
-
(GR) Greece: Pronoran;
-
(IN) India: Trivastal l.a.;
-
(JO) Jordan: Trivastal;
-
(LU) Luxembourg: Trivastal;
-
(MY) Malaysia: Trivastal;
-
(PH) Philippines: Trivastal;
-
(PK) Pakistan: Trivastal;
-
(PL) Poland: Trivastal;
-
(QA) Qatar: Trivastal;
-
(RU) Russian Federation: Pronokognil | Pronoran;
-
(SA) Saudi Arabia: Trivastal;
-
(SG) Singapore: Trivastal;
-
(TH) Thailand: Trivastal;
-
(VE) Venezuela, Bolivarian Republic of: Trivastal
Pharmacologic Category
-
Anti-Parkinson's Agent, Dopamine Agonist
Reported Use
Treatment of Parkinson disease, either as monotherapy without levodopa or in combination with levodopa therapy
Dosage Range
Parkinson disease: Oral: Note: Dosage should be introduced gradually, may increase by 50 mg every 3 days
Patients NOT on levodopa therapy: 150 mg to 250 mg daily in 3 to 5 divided doses
Combination with levodopa therapy: Reduced dosages may be given as a supplement to levodopa therapy (ie, 20 mg piribedil per 100 mg levodopa; 80 mg to 140 mg daily). Note: Use of 20 mg tablets is more suitable for this indication; however, availability of 20 mg tablets may vary per country/region.
Product Availability
Product available in various countries; not currently available in the US
Dosage Forms
Tablet, sustained release: 50 mg
Topic 10519 Version 53.0